First Oral Medication to Treat Moderate-to-Severe Crohn’s Disease Earns FDA Approval


Upadacitinib, the first oral treatment for Crohn's disease, has been approved by the Food and Drug Administration. The approval came in part through a Mount Sinai-led clinical trial that showed it to be more efficacious than placebo.

Learn More